Application | Comment | Organism |
---|---|---|
medicine | enzyme MAGL represents a potential target to treat diverse pathological conditions, including cancer | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(4-[4-chlorobenzoyl]piperidin-1-yl)(4-methoxyphenyl)-methanone | - |
Homo sapiens | |
2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-2-O-acetyl-4-O-(4-coumaroyl)-beta-D-glucopyranoside | - |
Homo sapiens | |
2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-2-O-acetyl-4-O-beta-D-glucopyranoside | the inhibitor is selective for hMAGL over hLDH, modeling of the binding mode in the MAGL active site. The sugar moiety lies in the wide lipophilic cavity of the protein forming lipophilic interactions with L148, L213, L241, and V183, whereas the 4-hydroxyphenyl-ethyl ring lies into the small pocket of the binding site and forms lipophilic interactions with residues Y194 and V270. A high number of H-bonds stabilizes the binding disposition of the compound | Homo sapiens | |
2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-beta-D-glucopyranoside | - |
Homo sapiens | |
brandioside | - |
Homo sapiens | |
additional information | phenylethanoid glycosides isolated from the n-butanol extract of Cistanche phelypaea aerial parts (collected in March 2012 in the southwest of Algeria) show activity as inhibitors of monoacylglycerol lipase, structure determinations by spectroscopic analyses, including 1D and 2D NMR, and HRESIMS experiments, docking study, overview. No inhibition by galloflavin, apigenin 7-O-beta-D-glucuronopyranoside, and 2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-2-O-acetyl-4-O-(4-coumaroyl)-beta-D-glucopyranoside | Homo sapiens | |
pinoresinol 4-O-beta-D-glucopyranoside | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q99685 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
4-nitrophenyl acetate + H2O | - |
Homo sapiens | 4-nitrophenol + acetate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
MAGL | - |
Homo sapiens |
monoacylglycerol lipase | - |
Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.2 | - |
assay at | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.088 | - |
pH 7.4, temperature not specified in the publication | Homo sapiens | 2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-2-O-acetyl-4-O-beta-D-glucopyranoside | |
0.1139 | - |
pH 7.4, temperature not specified in the publication | Homo sapiens | 2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-2-O-acetyl-4-O-(4-coumaroyl)-beta-D-glucopyranoside | |
0.1174 | - |
pH 7.4, temperature not specified in the publication | Homo sapiens | 2-(4-hydroxyphenyl)ethyl alpha-L-rhamnopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->6)]-beta-D-glucopyranoside |
General Information | Comment | Organism |
---|---|---|
physiological function | MAGL is a serine hydrolase that cleaves monoacyglycerols into fatty acids and glycerol. In particular, MAGL is the lipolytic enzyme that is mainly responsible for the degradation of the endocannabinoid 2-arachidonoylglycerol, which is a neurotransmitter and an important intermediate in lipid metabolism involved in many physiological processes. Moreover, the intensified production of fatty acids in cancer cells, generated by MAGL activity, increases the formation of protumorigenic signaling molecules | Homo sapiens |